MicroBiome Therapeutics is Biotechnology in United States that focus on microbiome modulators business. Founded in 2009. They cover business area such as developer, microbiome modulator, metabolic disease, health status, microbial population, their environment, fermentable fiber, polyphenol antioxidant, certain bacterial strain, nurture, beneficial microorganism.
2009
( 15 years old in 2024 )
Microbiome Modulators
-
Gertrude Pfost
5500 Prytania Street, Suite 530
New Orleans, LA 70115
United States
Private
developermicrobiome modulatormetabolic diseasehealth statusmicrobial populationtheir environmentfermentable fiberpolyphenol antioxidantcertain bacterial strainnurturebeneficial microorganism
* We use standard office opening hours in near MicroBiome Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MicroBiome Therapeutics is Biotechnology business from United States that founded in 2009 (15 years old in 2024), MicroBiome Therapeutics business is focusing on Microbiome Modulators.
MicroBiome Therapeutics headquarter office and corporate office address is located in Gertrude Pfost 5500 Prytania Street, Suite 530 New Orleans, LA 70115 United States.
MicroBiome Therapeutics was founded in United States.
In 2024, MicroBiome Therapeutics is currently focus on microbiome modulators sector.
Above is snippet of Google Trends for "microbiome modulators" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MicroBiome Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
